We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
  1. You have to credit our authors.
  2. You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
  3. You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
  4. If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
  5. The easiest way to get the article on your site is to embed the code below.
For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

Malaria kills more than a million people a year — or at least one person every 30 seconds — almost all of them in sub-Saharan Africa.

The announcement this week that sequencing of the genome of Plasmodium falciparum, the deadliest malaria parasite, is complete, could generate new approaches and targets for drug and vaccine discovery.

But, as Declan Butler reports in this feature article, the availability of the P. falciparum genome does not herald the parasite’s impending doom.

Link to Nature feature article

Reference: Nature 419, 426 (2002)

Related topics